Clarus Therapeutics Holdings Other Current Liabilities

Clarus Therapeutics Holdings (CRXT) currently reports a other current liabilities of $9.8M as of June 2022. That compares with $11M in the prior-year period — down 10.6% year over year. Use the charts on this page to explore Clarus Therapeutics Holdings's other current liabilities history and peer comparisons.

Clarus Therapeutics Holdings's other current liabilities decreased from $11M to $9.8M — a 10.6% year-over-year decrease (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clarus Therapeutics Holdings reported $9.8M in other current liabilities as of June 2022. That compares with $11M in the prior-year period — down 10.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $9.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clarus Therapeutics Holdings, and consider following CRXT for alerts when major investors trade the stock.